nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.0159	0.281	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.0135	0.239	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.00634	0.112	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.0059	0.104	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—NOS2—psoriatic arthritis	0.00331	0.0583	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.0028	0.0495	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—CRP—psoriatic arthritis	0.00228	0.0402	CbGpPWpGaD
Cefaclor—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00223	0.00237	CcSEcCtD
Cefaclor—Neutropenia—Methotrexate—psoriatic arthritis	0.00223	0.00236	CcSEcCtD
Cefaclor—Dysuria—Methotrexate—psoriatic arthritis	0.00223	0.00236	CcSEcCtD
Cefaclor—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00221	0.00234	CcSEcCtD
Cefaclor—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00221	0.00234	CcSEcCtD
Cefaclor—Shock—Prednisolone—psoriatic arthritis	0.0022	0.00233	CcSEcCtD
Cefaclor—Cough—Triamcinolone—psoriatic arthritis	0.00219	0.00233	CcSEcCtD
Cefaclor—Convulsion—Triamcinolone—psoriatic arthritis	0.00218	0.00231	CcSEcCtD
Cefaclor—Convulsion—Methylprednisolone—psoriatic arthritis	0.00217	0.0023	CcSEcCtD
Cefaclor—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00216	0.00229	CcSEcCtD
Cefaclor—Myalgia—Triamcinolone—psoriatic arthritis	0.00214	0.00227	CcSEcCtD
Cefaclor—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00214	0.00226	CcSEcCtD
Cefaclor—Myalgia—Methylprednisolone—psoriatic arthritis	0.00214	0.00226	CcSEcCtD
Cefaclor—Anxiety—Methylprednisolone—psoriatic arthritis	0.00213	0.00226	CcSEcCtD
Cefaclor—Infestation NOS—Methotrexate—psoriatic arthritis	0.00212	0.00225	CcSEcCtD
Cefaclor—Infestation—Methotrexate—psoriatic arthritis	0.00212	0.00225	CcSEcCtD
Cefaclor—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00212	0.00224	CcSEcCtD
Cefaclor—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00212	0.00224	CcSEcCtD
Cefaclor—Discomfort—Triamcinolone—psoriatic arthritis	0.00212	0.00224	CcSEcCtD
Cefaclor—Discomfort—Methylprednisolone—psoriatic arthritis	0.00211	0.00224	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00211	0.00223	CcSEcCtD
Cefaclor—Angioedema—Betamethasone—psoriatic arthritis	0.00208	0.00221	CcSEcCtD
Cefaclor—Angioedema—Dexamethasone—psoriatic arthritis	0.00208	0.00221	CcSEcCtD
Cefaclor—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00207	0.00219	CcSEcCtD
Cefaclor—Confusional state—Methylprednisolone—psoriatic arthritis	0.00206	0.00219	CcSEcCtD
Cefaclor—Immune system disorder—Prednisone—psoriatic arthritis	0.00206	0.00219	CcSEcCtD
Cefaclor—Malaise—Betamethasone—psoriatic arthritis	0.00206	0.00218	CcSEcCtD
Cefaclor—Malaise—Dexamethasone—psoriatic arthritis	0.00206	0.00218	CcSEcCtD
Cefaclor—Oedema—Triamcinolone—psoriatic arthritis	0.00205	0.00218	CcSEcCtD
Cefaclor—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00205	0.00218	CcSEcCtD
Cefaclor—Vertigo—Betamethasone—psoriatic arthritis	0.00205	0.00217	CcSEcCtD
Cefaclor—Vertigo—Dexamethasone—psoriatic arthritis	0.00205	0.00217	CcSEcCtD
Cefaclor—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00205	0.00217	CcSEcCtD
Cefaclor—Syncope—Dexamethasone—psoriatic arthritis	0.00205	0.00217	CcSEcCtD
Cefaclor—Syncope—Betamethasone—psoriatic arthritis	0.00205	0.00217	CcSEcCtD
Cefaclor—Sweating—Methotrexate—psoriatic arthritis	0.00204	0.00216	CcSEcCtD
Cefaclor—Haematuria—Methotrexate—psoriatic arthritis	0.00203	0.00215	CcSEcCtD
Cefaclor—Shock—Triamcinolone—psoriatic arthritis	0.00202	0.00214	CcSEcCtD
Cefaclor—Insomnia—Prednisolone—psoriatic arthritis	0.00202	0.00214	CcSEcCtD
Cefaclor—Shock—Methylprednisolone—psoriatic arthritis	0.00201	0.00214	CcSEcCtD
Cefaclor—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00201	0.00213	CcSEcCtD
Cefaclor—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00201	0.00213	CcSEcCtD
Cefaclor—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00201	0.00213	CcSEcCtD
Cefaclor—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00201	0.00213	CcSEcCtD
Cefaclor—Epistaxis—Methotrexate—psoriatic arthritis	0.002	0.00212	CcSEcCtD
Cefaclor—Paraesthesia—Prednisolone—psoriatic arthritis	0.002	0.00212	CcSEcCtD
Cefaclor—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00198	0.0021	CcSEcCtD
Cefaclor—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00198	0.0021	CcSEcCtD
Cefaclor—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00198	0.0021	CcSEcCtD
Cefaclor—Convulsion—Betamethasone—psoriatic arthritis	0.00198	0.0021	CcSEcCtD
Cefaclor—Convulsion—Dexamethasone—psoriatic arthritis	0.00198	0.0021	CcSEcCtD
Cefaclor—Myalgia—Betamethasone—psoriatic arthritis	0.00194	0.00206	CcSEcCtD
Cefaclor—Myalgia—Dexamethasone—psoriatic arthritis	0.00194	0.00206	CcSEcCtD
Cefaclor—Anxiety—Dexamethasone—psoriatic arthritis	0.00194	0.00205	CcSEcCtD
Cefaclor—Anxiety—Betamethasone—psoriatic arthritis	0.00194	0.00205	CcSEcCtD
Cefaclor—Discomfort—Dexamethasone—psoriatic arthritis	0.00192	0.00203	CcSEcCtD
Cefaclor—Discomfort—Betamethasone—psoriatic arthritis	0.00192	0.00203	CcSEcCtD
Cefaclor—Haemoglobin—Methotrexate—psoriatic arthritis	0.00192	0.00203	CcSEcCtD
Cefaclor—Hypotension—Methylprednisolone—psoriatic arthritis	0.00191	0.00203	CcSEcCtD
Cefaclor—Pain—Prednisolone—psoriatic arthritis	0.00191	0.00202	CcSEcCtD
Cefaclor—Haemorrhage—Methotrexate—psoriatic arthritis	0.00191	0.00202	CcSEcCtD
Cefaclor—Hepatitis—Methotrexate—psoriatic arthritis	0.00191	0.00202	CcSEcCtD
Cefaclor—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00188	0.002	CcSEcCtD
Cefaclor—Urethral disorder—Methotrexate—psoriatic arthritis	0.00187	0.00198	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00187	0.00198	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00187	0.00198	CcSEcCtD
Cefaclor—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00186	0.00197	CcSEcCtD
Cefaclor—Oedema—Betamethasone—psoriatic arthritis	0.00186	0.00197	CcSEcCtD
Cefaclor—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00186	0.00197	CcSEcCtD
Cefaclor—Oedema—Dexamethasone—psoriatic arthritis	0.00186	0.00197	CcSEcCtD
Cefaclor—Insomnia—Triamcinolone—psoriatic arthritis	0.00186	0.00197	CcSEcCtD
Cefaclor—Insomnia—Methylprednisolone—psoriatic arthritis	0.00185	0.00196	CcSEcCtD
Cefaclor—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00184	0.00195	CcSEcCtD
Cefaclor—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00184	0.00195	CcSEcCtD
Cefaclor—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00184	0.00195	CcSEcCtD
Cefaclor—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00184	0.00195	CcSEcCtD
Cefaclor—Shock—Dexamethasone—psoriatic arthritis	0.00183	0.00194	CcSEcCtD
Cefaclor—Shock—Betamethasone—psoriatic arthritis	0.00183	0.00194	CcSEcCtD
Cefaclor—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00183	0.00194	CcSEcCtD
Cefaclor—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00183	0.00194	CcSEcCtD
Cefaclor—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00183	0.00194	CcSEcCtD
Cefaclor—Agitation—Prednisone—psoriatic arthritis	0.00183	0.00194	CcSEcCtD
Cefaclor—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00182	0.00193	CcSEcCtD
Cefaclor—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00182	0.00193	CcSEcCtD
Cefaclor—Angioedema—Prednisone—psoriatic arthritis	0.00182	0.00192	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.00181	0.032	CbGpPWpGaD
Cefaclor—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00181	0.00192	CcSEcCtD
Cefaclor—Erythema multiforme—Methotrexate—psoriatic arthritis	0.0018	0.00191	CcSEcCtD
Cefaclor—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0018	0.00191	CcSEcCtD
Cefaclor—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.0018	0.00191	CcSEcCtD
Cefaclor—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.0018	0.00191	CcSEcCtD
Cefaclor—Malaise—Prednisone—psoriatic arthritis	0.00179	0.0019	CcSEcCtD
Cefaclor—Vertigo—Prednisone—psoriatic arthritis	0.00179	0.00189	CcSEcCtD
Cefaclor—Syncope—Prednisone—psoriatic arthritis	0.00178	0.00189	CcSEcCtD
Cefaclor—Anorexia—Betamethasone—psoriatic arthritis	0.00177	0.00188	CcSEcCtD
Cefaclor—Anorexia—Dexamethasone—psoriatic arthritis	0.00177	0.00188	CcSEcCtD
Cefaclor—Urticaria—Prednisolone—psoriatic arthritis	0.00177	0.00188	CcSEcCtD
Cefaclor—Pain—Triamcinolone—psoriatic arthritis	0.00175	0.00186	CcSEcCtD
Cefaclor—Loss of consciousness—Prednisone—psoriatic arthritis	0.00175	0.00185	CcSEcCtD
Cefaclor—Hypotension—Dexamethasone—psoriatic arthritis	0.00174	0.00184	CcSEcCtD
Cefaclor—Hypotension—Betamethasone—psoriatic arthritis	0.00174	0.00184	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—psoriatic arthritis	0.00172	0.00183	CcSEcCtD
Cefaclor—Convulsion—Prednisone—psoriatic arthritis	0.00172	0.00182	CcSEcCtD
Cefaclor—Chills—Methotrexate—psoriatic arthritis	0.00171	0.00181	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.0017	0.0018	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.0017	0.0018	CcSEcCtD
Cefaclor—Myalgia—Prednisone—psoriatic arthritis	0.00169	0.00179	CcSEcCtD
Cefaclor—Arthralgia—Prednisone—psoriatic arthritis	0.00169	0.00179	CcSEcCtD
Cefaclor—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00169	0.00179	CcSEcCtD
Cefaclor—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00169	0.00179	CcSEcCtD
Cefaclor—Anxiety—Prednisone—psoriatic arthritis	0.00169	0.00179	CcSEcCtD
Cefaclor—Insomnia—Betamethasone—psoriatic arthritis	0.00168	0.00179	CcSEcCtD
Cefaclor—Insomnia—Dexamethasone—psoriatic arthritis	0.00168	0.00179	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00167	0.00178	CcSEcCtD
Cefaclor—Paraesthesia—Betamethasone—psoriatic arthritis	0.00167	0.00177	CcSEcCtD
Cefaclor—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00167	0.00177	CcSEcCtD
Cefaclor—Discomfort—Prednisone—psoriatic arthritis	0.00167	0.00177	CcSEcCtD
Cefaclor—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00164	0.00174	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—TNF—psoriatic arthritis	0.00164	0.0289	CbGpPWpGaD
Cefaclor—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00164	0.00174	CcSEcCtD
Cefaclor—Dyspepsia—Betamethasone—psoriatic arthritis	0.00164	0.00174	CcSEcCtD
Cefaclor—Urticaria—Triamcinolone—psoriatic arthritis	0.00163	0.00173	CcSEcCtD
Cefaclor—Urticaria—Methylprednisolone—psoriatic arthritis	0.00163	0.00172	CcSEcCtD
Cefaclor—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00162	0.00172	CcSEcCtD
Cefaclor—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00162	0.00172	CcSEcCtD
Cefaclor—Oedema—Prednisone—psoriatic arthritis	0.00162	0.00172	CcSEcCtD
Cefaclor—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00162	0.00172	CcSEcCtD
Cefaclor—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00162	0.00172	CcSEcCtD
Cefaclor—Decreased appetite—Betamethasone—psoriatic arthritis	0.00162	0.00172	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00161	0.0017	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00161	0.0017	CcSEcCtD
Cefaclor—Back pain—Methotrexate—psoriatic arthritis	0.00161	0.0017	CcSEcCtD
Cefaclor—Shock—Prednisone—psoriatic arthritis	0.0016	0.00169	CcSEcCtD
Cefaclor—Pain—Betamethasone—psoriatic arthritis	0.00159	0.00169	CcSEcCtD
Cefaclor—Pain—Dexamethasone—psoriatic arthritis	0.00159	0.00169	CcSEcCtD
Cefaclor—Nervous system disorder—Prednisone—psoriatic arthritis	0.00159	0.00169	CcSEcCtD
Cefaclor—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00157	0.00166	CcSEcCtD
Cefaclor—Anorexia—Prednisone—psoriatic arthritis	0.00155	0.00164	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00154	0.00163	CcSEcCtD
Cefaclor—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00153	0.00163	CcSEcCtD
Cefaclor—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00153	0.00163	CcSEcCtD
Cefaclor—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00152	0.00161	CcSEcCtD
Cefaclor—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00152	0.00161	CcSEcCtD
Cefaclor—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00151	0.0016	CcSEcCtD
Cefaclor—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00151	0.0016	CcSEcCtD
Cefaclor—Malaise—Methotrexate—psoriatic arthritis	0.0015	0.00159	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—psoriatic arthritis	0.00149	0.00158	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—psoriatic arthritis	0.00149	0.00158	CcSEcCtD
Cefaclor—Urticaria—Dexamethasone—psoriatic arthritis	0.00148	0.00157	CcSEcCtD
Cefaclor—Urticaria—Betamethasone—psoriatic arthritis	0.00148	0.00157	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00148	0.00157	CcSEcCtD
Cefaclor—Dizziness—Prednisolone—psoriatic arthritis	0.00148	0.00156	CcSEcCtD
Cefaclor—Asthenia—Triamcinolone—psoriatic arthritis	0.00147	0.00156	CcSEcCtD
Cefaclor—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00147	0.00156	CcSEcCtD
Cefaclor—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00147	0.00156	CcSEcCtD
Cefaclor—Abdominal pain—Betamethasone—psoriatic arthritis	0.00147	0.00156	CcSEcCtD
Cefaclor—Body temperature increased—Betamethasone—psoriatic arthritis	0.00147	0.00156	CcSEcCtD
Cefaclor—Asthenia—Methylprednisolone—psoriatic arthritis	0.00147	0.00156	CcSEcCtD
Cefaclor—Insomnia—Prednisone—psoriatic arthritis	0.00147	0.00155	CcSEcCtD
Cefaclor—Paraesthesia—Prednisone—psoriatic arthritis	0.00146	0.00154	CcSEcCtD
Cefaclor—Pruritus—Triamcinolone—psoriatic arthritis	0.00145	0.00154	CcSEcCtD
Cefaclor—Cough—Methotrexate—psoriatic arthritis	0.00145	0.00154	CcSEcCtD
Cefaclor—Pruritus—Methylprednisolone—psoriatic arthritis	0.00145	0.00154	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—psoriatic arthritis	0.00144	0.00153	CcSEcCtD
Cefaclor—Dyspepsia—Prednisone—psoriatic arthritis	0.00143	0.00151	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—psoriatic arthritis	0.00141	0.0015	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—psoriatic arthritis	0.00141	0.0015	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—psoriatic arthritis	0.00141	0.0015	CcSEcCtD
Cefaclor—Decreased appetite—Prednisone—psoriatic arthritis	0.00141	0.00149	CcSEcCtD
Cefaclor—Rash—Prednisolone—psoriatic arthritis	0.00141	0.00149	CcSEcCtD
Cefaclor—Dermatitis—Prednisolone—psoriatic arthritis	0.00141	0.00149	CcSEcCtD
Cefaclor—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.0014	0.00149	CcSEcCtD
Cefaclor—Headache—Prednisolone—psoriatic arthritis	0.0014	0.00148	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—psoriatic arthritis	0.0014	0.00148	CcSEcCtD
Cefaclor—Constipation—Prednisone—psoriatic arthritis	0.00139	0.00147	CcSEcCtD
Cefaclor—Confusional state—Methotrexate—psoriatic arthritis	0.00137	0.00145	CcSEcCtD
Cefaclor—Dizziness—Triamcinolone—psoriatic arthritis	0.00136	0.00144	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00136	0.00144	CcSEcCtD
Cefaclor—Dizziness—Methylprednisolone—psoriatic arthritis	0.00135	0.00144	CcSEcCtD
Cefaclor—Feeling abnormal—Prednisone—psoriatic arthritis	0.00134	0.00142	CcSEcCtD
Cefaclor—Asthenia—Betamethasone—psoriatic arthritis	0.00134	0.00142	CcSEcCtD
Cefaclor—Asthenia—Dexamethasone—psoriatic arthritis	0.00134	0.00142	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00133	0.00141	CcSEcCtD
Cefaclor—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00133	0.00141	CcSEcCtD
Cefaclor—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00133	0.00141	CcSEcCtD
Cefaclor—Nausea—Prednisolone—psoriatic arthritis	0.00133	0.00141	CcSEcCtD
Cefaclor—Pruritus—Betamethasone—psoriatic arthritis	0.00132	0.0014	CcSEcCtD
Cefaclor—Pruritus—Dexamethasone—psoriatic arthritis	0.00132	0.0014	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00131	0.00139	CcSEcCtD
Cefaclor—Vomiting—Triamcinolone—psoriatic arthritis	0.0013	0.00138	CcSEcCtD
Cefaclor—Vomiting—Methylprednisolone—psoriatic arthritis	0.0013	0.00138	CcSEcCtD
Cefaclor—Rash—Triamcinolone—psoriatic arthritis	0.00129	0.00137	CcSEcCtD
Cefaclor—Dermatitis—Triamcinolone—psoriatic arthritis	0.00129	0.00137	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—psoriatic arthritis	0.00129	0.00137	CcSEcCtD
Cefaclor—Rash—Methylprednisolone—psoriatic arthritis	0.00129	0.00137	CcSEcCtD
Cefaclor—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00129	0.00137	CcSEcCtD
Cefaclor—Urticaria—Prednisone—psoriatic arthritis	0.00129	0.00137	CcSEcCtD
Cefaclor—Headache—Triamcinolone—psoriatic arthritis	0.00129	0.00136	CcSEcCtD
Cefaclor—Headache—Methylprednisolone—psoriatic arthritis	0.00128	0.00136	CcSEcCtD
Cefaclor—Abdominal pain—Prednisone—psoriatic arthritis	0.00128	0.00136	CcSEcCtD
Cefaclor—Body temperature increased—Prednisone—psoriatic arthritis	0.00128	0.00136	CcSEcCtD
Cefaclor—Diarrhoea—Betamethasone—psoriatic arthritis	0.00127	0.00135	CcSEcCtD
Cefaclor—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00127	0.00135	CcSEcCtD
Cefaclor—MPO—Vitamin B12 Metabolism—TNF—psoriatic arthritis	0.00127	0.0224	CbGpPWpGaD
Cefaclor—Hypotension—Methotrexate—psoriatic arthritis	0.00127	0.00134	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00123	0.00131	CcSEcCtD
Cefaclor—Dizziness—Betamethasone—psoriatic arthritis	0.00123	0.00131	CcSEcCtD
Cefaclor—Dizziness—Dexamethasone—psoriatic arthritis	0.00123	0.00131	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—psoriatic arthritis	0.00123	0.0013	CcSEcCtD
Cefaclor—Nausea—Triamcinolone—psoriatic arthritis	0.00122	0.00129	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—psoriatic arthritis	0.00122	0.00129	CcSEcCtD
Cefaclor—Nausea—Methylprednisolone—psoriatic arthritis	0.00122	0.00129	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—psoriatic arthritis	0.00121	0.00128	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—psoriatic arthritis	0.0012	0.00128	CcSEcCtD
Cefaclor—Hypersensitivity—Prednisone—psoriatic arthritis	0.00119	0.00127	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—psoriatic arthritis	0.00119	0.00126	CcSEcCtD
Cefaclor—Vomiting—Dexamethasone—psoriatic arthritis	0.00118	0.00126	CcSEcCtD
Cefaclor—Vomiting—Betamethasone—psoriatic arthritis	0.00118	0.00126	CcSEcCtD
Cefaclor—Decreased appetite—Methotrexate—psoriatic arthritis	0.00118	0.00125	CcSEcCtD
Cefaclor—Rash—Betamethasone—psoriatic arthritis	0.00117	0.00124	CcSEcCtD
Cefaclor—Rash—Dexamethasone—psoriatic arthritis	0.00117	0.00124	CcSEcCtD
Cefaclor—Dermatitis—Dexamethasone—psoriatic arthritis	0.00117	0.00124	CcSEcCtD
Cefaclor—Dermatitis—Betamethasone—psoriatic arthritis	0.00117	0.00124	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00117	0.00124	CcSEcCtD
Cefaclor—Headache—Dexamethasone—psoriatic arthritis	0.00117	0.00124	CcSEcCtD
Cefaclor—Headache—Betamethasone—psoriatic arthritis	0.00117	0.00124	CcSEcCtD
Cefaclor—Asthenia—Prednisone—psoriatic arthritis	0.00116	0.00123	CcSEcCtD
Cefaclor—Pain—Methotrexate—psoriatic arthritis	0.00116	0.00123	CcSEcCtD
Cefaclor—Pruritus—Prednisone—psoriatic arthritis	0.00115	0.00122	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00112	0.00118	CcSEcCtD
Cefaclor—Diarrhoea—Prednisone—psoriatic arthritis	0.00111	0.00118	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00111	0.00117	CcSEcCtD
Cefaclor—Nausea—Dexamethasone—psoriatic arthritis	0.00111	0.00117	CcSEcCtD
Cefaclor—Nausea—Betamethasone—psoriatic arthritis	0.00111	0.00117	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—psoriatic arthritis	0.00108	0.00114	CcSEcCtD
Cefaclor—Dizziness—Prednisone—psoriatic arthritis	0.00107	0.00114	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—psoriatic arthritis	0.00107	0.00114	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—psoriatic arthritis	0.00107	0.00114	CcSEcCtD
Cefaclor—MPO—Folate Metabolism—TNF—psoriatic arthritis	0.00103	0.0182	CbGpPWpGaD
Cefaclor—Vomiting—Prednisone—psoriatic arthritis	0.00103	0.00109	CcSEcCtD
Cefaclor—Rash—Prednisone—psoriatic arthritis	0.00102	0.00108	CcSEcCtD
Cefaclor—Dermatitis—Prednisone—psoriatic arthritis	0.00102	0.00108	CcSEcCtD
Cefaclor—Headache—Prednisone—psoriatic arthritis	0.00102	0.00108	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000998	0.00106	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—psoriatic arthritis	0.000972	0.00103	CcSEcCtD
Cefaclor—Nausea—Prednisone—psoriatic arthritis	0.000963	0.00102	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—psoriatic arthritis	0.000959	0.00102	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—psoriatic arthritis	0.000927	0.000983	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—psoriatic arthritis	0.000896	0.00095	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—psoriatic arthritis	0.000862	0.000913	CcSEcCtD
Cefaclor—Rash—Methotrexate—psoriatic arthritis	0.000854	0.000906	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—psoriatic arthritis	0.000854	0.000905	CcSEcCtD
Cefaclor—Headache—Methotrexate—psoriatic arthritis	0.000849	0.0009	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.00082	0.0145	CbGpPWpGaD
Cefaclor—Nausea—Methotrexate—psoriatic arthritis	0.000805	0.000853	CcSEcCtD
